nalmefene has been researched along with Disease Models, Animal in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Kang, P; Wang, HQ; Yang, J; Yang, P; Zhang, NL; Zhao, T | 1 |
| Browne, CA; Lucki, I; Smith, T | 1 |
| Bidlack, JM; Callaghan, CK; Dean, RL; Deaver, DR; Knapp, BI; O'Mara, SM; Rouine, J | 1 |
| Bont, L; Gharagozlou, MJ; Golara, M; Jamali, A; Mahmoodi, M; Minaei, B; Mirzaei, H; Mokhtari-Azad, T; Ramezani, A; Salimi, V; Shahabi, S; Shokri, F; Tahamtan, A | 1 |
| Diouf, M; González-Marín, MC; Jeanblanc, J; Lebourgeois, S; Naassila, M | 1 |
| Hackett, D; Heal, DJ; Hutson, PH; Murray, F; Vickers, SP | 1 |
| Dudek, M; Herr, DR; Hytönen, HR; Hyytiä, P; Korpi, ER; Linden, AM; Paasikoski, N; Vashchinkina, E | 1 |
| Bilsky, EJ; Giuvelis, D; Lowery, JJ; Osborn, MD; Skorput, AG | 1 |
| Clemens, MG; Day, SA; Lakner, AM; Moore, CC; Schrum, LW; Wu, ES; Yen, MH | 1 |
| June, HL | 1 |
| Faden, AI; McIntosh, TK; Rhomhanyi, R; Vink, R | 1 |
12 other study(ies) available for nalmefene and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Effects of nalmefene hydrochloride on TLR4 signaling pathway in rats with lung ischemia-reperfusion injury.
Topics: Acute Lung Injury; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Thoracotomy; Toll-Like Receptor 4 | 2020 |
Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression.
Topics: Animals; Behavior Observation Techniques; Behavior, Animal; Depression; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Female; Humans; Male; Mice; Mice, Knockout; Naltrexone; Nucleus Accumbens; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Factors | 2020 |
Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-α-induced depression model.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cell Proliferation; Depression; Depressive Disorder; Disease Models, Animal; Hippocampus; Interferon-alpha; Male; Naltrexone; Narcotic Antagonists; Neurons; Rats, Wistar; Receptors, Opioid | 2018 |
Blocking of opioid receptors in experimental formaline-inactivated respiratory syncytial virus (FI-RSV) immunopathogenesis: from beneficial to harmful impacts.
Topics: Animals; Body Weight; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Immunologic Factors; Lung; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; T-Lymphocyte Subsets; Viral Load | 2018 |
Evaluation of alcohol use disorders pharmacotherapies in a new preclinical model of binge drinking.
Topics: Acamprosate; Animals; Baclofen; Binge Drinking; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Extinction, Psychological; Hydroxybutyrates; Male; Motivation; Naltrexone; Rats; Self Administration | 2018 |
Effects of lisdexamfetamine in a rat model of binge-eating.
Topics: Animals; Baclofen; Behavior, Animal; Benzazepines; Benzodiazepines; Body Weight; Bulimia; Disease Models, Animal; Eating; Feeding Behavior; Female; Idazoxan; Lisdexamfetamine Dimesylate; Naltrexone; Olanzapine; Prazosin; Prodrugs; Raclopride; Rats; Rats, Wistar; Rolipram | 2015 |
Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors.
Topics: Alcoholism; Animals; Brain; Disease Models, Animal; Ethanol; Female; Naltrexone; Narcotic Antagonists; Rats; Receptors, Opioid | 2017 |
In vivo characterization of the opioid antagonist nalmefene in mice.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Male; Mice; Mice, Inbred ICR; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Pain; Substance Withdrawal Syndrome; Time Factors | 2010 |
Opioid-like compound exerts anti-fibrotic activity via decreased hepatic stellate cell activation and inflammation.
Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Collagen; Disease Models, Animal; Hepatic Stellate Cells; Immunoblotting; Liver Cirrhosis; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Morphinans; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Preclinical models to evaluate potential pharmacotherapeutic agents in treating alcoholism and studying the neuropharmacological bases of ethanol-seeking behaviors in rats.
Topics: Alcohol Drinking; Alcoholism; Animals; Behavior, Addictive; Disease Models, Animal; Drug Evaluation, Preclinical; Ethanol; Female; Male; Naltrexone; Rats; Reinforcement Schedule | 2002 |
Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Brain Injuries; Disease Models, Animal; Energy Metabolism; Magnesium; Magnetic Resonance Spectroscopy; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Phosphates; Phosphocreatine; Phosphorus; Rats; Rats, Inbred Strains | 1990 |